280 likes | 356 Views
This guide covers risk assessment factors, procedures, and equipment to ensure safe research practices in animal biosafety. Learn about species, infections, safe work practices, and more. Follow the risk assessment process, engage with committees, and prioritize personnel safety. Understand the importance of proper equipment, protocols, and facility compliance. Prepare for proposed procedures, personnel requirements, and working with sharps. Stay informed about facility guidelines, regulations, and expert recommendations to enhance safety. Always be cautious, communicate decisions, and adapt to evolving risk management needs.
E N D
Risk Assessment in Animal Biosafety • Risk Assessment Factors • Pathogen/agent • Animal Model (species) • Procedures • Proposed manipulations • Assigned safe work practices
Risk Assessment in Animal Biosafety • Risk Assessment Factors • Personnel • Protective Equipment • Personal Protective Equipment/Clothing • Engineering Controls/Safety Devices • Place/Facility for proposed research
Risk Assessment in Animal Biosafety • Species • Natural infections • Unpredictable - physical hazards • Bites/scratches/splashes • Permissive species • Immune system of animal • Shedding (urine, feces, sputum) • Data? Transmission between cage mates? Between cages within room?
Risk Assessment Process • Prior to initiation of work • Principal Investigator submits written risk assessment • Written proposal • Registration Form • Submitted to the IBC/IACUC/Biosafety Office
Committee Risk Assessment • Questions/clarification • Has PI started w/ Risk Group? Worked towards Biosafety Level? • Verify that PI has identified: • Risks involved • Routes of exposure (nature/ lab settings) • Signs/symptoms of infection • Potential for shedding from animals • At risk personnel (those contraindicated from work) • Any special medical surveillance requirements • Serum banking, immunizations, screening/evaluation
Committee Risk Assessment • Questions/clarification • Verify that PI has Selected the Appropriate: • BSL • Work Practices • PPE • Containment Equipment • To maximize protection of staff • Does Facility meet requirements for BSL selected?
Risk Assessment – Proposed Procedures • Manipulations planned with the animal • Blood collection • Tissue harvesting/necropsy • Aerosols, splash risk • Sharps • Genetic manipulation
Risk Assessment - Personnel • Immune status of host • Altered competency – suppression (disease, therapy) • Experience/Training WITH: • Agent • Animals • Procedures • Equipment • Facility • Safety Record/Attitude
Risk Assessment • Ensure that the PI’s group is involved in development of the SOP! • Take ownership
Risk Assessment – Equipment • Cages/housing • Open • Static, MI (Filtration Efficiency) • Ventilated Cage Racks w/ HEPA filters • PPE • Coat, gown, jump suits, full clothes change/shower • Masks, face protection, Respirators
Risk Assessment – Facility • Conformity w/ • ABSL-1, ABSL-2, and ABSL-3 Facilities • Compliance with pertinent: • Guidelines • Regulations • Standards • Enhanced Facilities
Risk Assessment - Process • Professional Judgment Required • Expertise • IACUC • Animal model, animal care and use, animal regulations • IBC/BSO • Agent, exposure routes, med. Surveillance, facility design, equipment use/certification • Principal Investigator • Disease under study, scientific aim, lab techniques
Risk Assessment - Process • After review of Risk Assessment Factors: • Select most appropriate BSL • PPE • Work Practices • Engineering Controls • Facility Controls • SOP’s prepared and approved • Clearance for each researcher/animal handler • Written Emergency Response Plans
Risk Assessment Process • When you don’t have all the answers? • Be Cautious/Conservative • RA is evolving/dynamic process • Change as info comes in • Communicate RA and RM decisions to all involved
LCMV – Risk Assessment Example • National Risk Group Classification • RG3 – neurotropic strains, RG2 – non-neurotropic strains • Previous LAI via airborne route • Shedding from animal (urine) • Clone 13 (persistent shedding) • Environmental stability (survives for weeks in animal waste)
LCMV – Risk Assessment Example • Use of sharps • Inoculations, bleeds, necropsies • Transport of tissues, infected cells, virus • Protective Clothing • Gowns, 2 pair of gloves, booties, face protection, Respiratory Protection • Protective Equipment • Microisolator cages, biosafety cabinets • Place – ABSL-3 facility
Location A Registration(s) IACUC IBC Location B Registration(s) IACUC IBC ARC Haz. Agent Form EHS RTUIA-Animals State Human Pathogen registration Case Study ExampleABSL-2 rDNA Protocol – Vaccinia Virus
Location A Review of Training IACUC Orientation Animal Handling Location B Review of Training IACUC Orientation Animal Handling EHS Classes Biosafety, BBP, Chem Researcher Experience Form Case Study ExampleABSL-2 rDNA – Vaccinia Virus
Location A Specific SOP created none Location B Specific SOP created Entry, exit, supplies Protective clothing Biosafety cabinet use Safe sharps (devices/use) Decontamination Emergency response Case Study ExampleABSL-2 rDNA – Vaccinia Virus
Location A Additional Requirements Medical Surveillance Health history form Location B Additional Requirements Medical Surveillance Health history form Vaccinia immunization consult Employee Health review Case Study ExampleABSL-2 rDNA – Vaccinia Virus
Location A Training/Inspection Facility orientation Location B Training/Inspection Facility orientation State DPH Inspection ARC/EHS/VC start-up meeting w/ researcher Researcher work practice observation Case Study ExampleABSL-2 rDNA – Vaccinia Virus
Location A Implementation Vaccinia needlestick No incident report Vaccinia LAI and bacterial sepsis Hospitalization Report to State DPH Report to NIH OBA (significant incident/illness) Location B Implementation No incidents to date Case Study ExampleABSL-2 rDNA – Vaccinia Virus